Skip to content

Author

Fotis Barkas

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Effect of Obicetrapib on Glycaemia and New-Onset Diabetes: Pooled Analysis of BROADWAY/BROOKLYN and an Updated Meta-analysis of CETP Inhibitor Trials.

AIMS New-onset diabetes (NoD) is a recognised effect of statin therapy potentially influencing acceptance of intensive LDL-C-lowering. In contrast, cholesteryl ester transfer protein (CETP) inhibition has been associated with lower NoD risk in earlier trials. We assessed the effect of the highly selective CETP inhibito...

J. Brandts, M. Szarek, S. J. Nicholls et al. · 0 citations
Open access Oct 2026

Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease

Atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD) impact health and healthcare systems. Inflammation is a potential modifiable risk factor for both conditions. The case for evaluating the modification of inflammation in these conditions could be strengthened by evidence that systemic...

Kausik K. Ray, Fotis Barkas, E. Huisman et al. · 0 citations
Aug 2026

Incidence and predictors of distal symmetrical polyneuropathy in prediabetes: A 24-month prospective cohort study.

BACKGROUND Distal symmetrical polyneuropathy (DSPN) is a prevalent complication of diabetes, with emerging evidence of onset in earlier stages of dysglycemia. Prediabetes is characterized by insulin resistance, central adiposity, and dyslipidemia. Data on the incidence of DSPN in prediabetes and possible association wi...

Georgia Anastasiou, Nikoloas Papanas, Fotis Barkas et al. · 0 citations
Review Open access Sep 2026

Features of Lipid Disorders in Cardiovascular–Kidney–Metabolic Syndrome

Current evidence on the pathophysiological mechanisms underlying CKM-related dyslipidaemia is examined and a practical framework for its assessment and management is provided to provide a practical framework for its assessment and management.

A. Ceasovschih, Y. Şener, M. Arici et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.